Abstract: An apparatus for reporting delay information, configured in a terminal equipment, includes: processor circuitry configured to determine a first remaining time; and a transmitter configured to transmit a delay information report to a network device, the delay information report including the first remaining time, and the processor circuitry triggers the delay information report in a case where the smallest value of remaining times of protocol data units at a packet data convergence protocol layer of the terminal equipment becomes lower than a configured threshold.

Abstract: Proposed are an apparatus for and a method of controlling a vehicle suspension. The apparatus includes a sensor configured to acquire at least one of information on a road surface in front of a vehicle and state information of the vehicle; and a processor configured to predict a vehicular behavior based on the information acquired through the sensor and actuator information and to control at least one of a ride height of the vehicle, stiffness of an air spring, and a damping force of a damper based on the predicted vehicular behavior.

Abstract: An apparatus, configured in a terminal equipment for packet data convergence protocol (PDCP) entity establishment, includes: processor circuitry configured to map at least one group of Protocol Data Unit (PDU) Sets to at least one data radio bearer; and establish at least one corresponding packet data convergence protocol (PDCP) entity for the at least one data radio bearer, wherein the at least one packet data convergence protocol (PDCP) entity shares first information.

Abstract: An apparatus for measurement relaxation, applicable to a terminal equipment, the apparatus includes a first controller, the first controller being configured to: for a serving cell configured with two or more beam failure detection reference signal (BFD-RS) sets, control the terminal equipment not to perform measurement relaxation of beam failure detection (BFD).

Abstract: An apparatus for cell switching, applicable to a terminal equipment, includes: a first receiver configured to receive a MAC CE (Control Element) from a first network node; and a processor circuitry configured to switch a serving cell to a cell indicated by the MAC CE, wherein the switching a serving cell to a cell indicated by the MAC CE comprises at least one of a L1 reset procedure, a L2 reset procedure, or processing a timer maintained by an RRC (Radio Resource Control) layer.

Abstract: An apparatus for configuring a cell, provided in a first network node, includes: a first transmitter configured to transmit configuration information on a group of candidate cells to a terminal equipment, the configuration information comprising cell identification information and information needed in accessing to a cell; and a second transmitter configured to transmit L1 signaling and/or L2 signaling to the terminal equipment, the L1 signaling and/or the L2 signaling indicating at least one cell in the group of candidate cells.

Abstract: A donor device, applicable to an F1-terminating donor-CU of a mobile IAB node, includes: a receiver configured to receive first indication information, the first indication information comprising identity information related to a third donor-CU which is an RRC-terminating donor-CU after migration or radio link failure recovery of the mobile IAB node; and a transmitter configured to transmit second indication information for indicating a context of a traffic to the third donor-CU.

Abstract: An integrated access and backhaul IAB donor-CU device, which is an F1-terminating donor-CU device of a migrating IAB node, includes: a transmitter configured to transmit IP address configuration information of an F1-terminating topology domain allocated for the migrating IAB node to a non-F1-terminating donor-CU; wherein IP address configuration information of the F1-terminating topology domain includes a TNL (transport network layer) address anchored at a donor-DU in the F1-terminating donor-CU topology for the migrating IAB node, and a receiver configured to receive IP address configuration information of the non-F1-terminating topology domain allocated for the migrating IAB node transmitted by the non-F1-terminating donor-CU; wherein IP address configuration information of the non-F1-terminating topology domain includes a new TNL address anchored at a donor-DU in the non-F1-terminating donor-CU topology for the migrating IAB node.

Abstract: The present invention relates to a composition for promoting myogenesis, containing, as an active ingredient, a processed ginseng extract in which a trace amount of a ginsenoside ingredient is increased. It has been ascertained that the processed ginseng extract promotes the differentiation of myoblasts into muscle and inhibits muscle atrophy caused by myostatin, which is a myogenesis inhibitory factor, and thus it is expected that a composition for preventing or treating muscle disorder-related diseases, having excellent effects, can be developed.

Abstract: Embodiments of this disclosure provide a method and apparatus for transmitting failure information and a system. The method for transmitting failure information includes: transmitting configuration information to a remote user equipment, the configuration information including information for adding and/or modifying and/or deleting a path, the path being a direct path and/or an indirect path between the remote user equipment and a network device.

Abstract: An apparatus for configuring information, applicable to an IAB-node (integrated access and backhaul node), includes: processor circuitry configured to match a topology in backhaul routing configuration indicated by a first type indicator with a topology to which a BAP (Backhaul Adaptation Protocol) data protocol data unit (PDU) belongs.

Abstract: A multi-path configuration apparatus, includes: a transmitter configured to transmit configuration information to a remote terminal equipment, the configuration information including information for adding a path such that the remote terminal equipment and a network device are connected via more than one path, the path being a direct path and/or an indirect path between the remote terminal equipment and the network device.

Abstract: Embodiments of this disclosure provide a multi-path processing method and apparatus, a device and a system. The multi-path processing method includes: receiving indication information, the indication information including information on activation and/or deactivation and/or handover of a direct path, and/or, including information on activation and/or deactivation and/or handover of an indirect path; and performing activation and/or deactivation and/or handover of the direct path, and/or perform activation and/or deactivation and/or handover of the indirect path, according to the indication information.

Abstract: An apparatus for evaluating downlink radio link quality, applicable to a terminal equipment, includes: first configuring processor circuitry configured to configure a secondary cell group (SCG); wherein in a case where a network indicates that the secondary cell group supports radio link monitoring (RLM), when the secondary cell group is deactivated, the terminal equipment performs radio link monitoring on a primary secondary cell (PSCell); and in a case where the network indicates that the secondary cell group supports beam failure detection and the primary secondary cell is not configured with two BFD-RS (Reference Signal) sets by the network, when the secondary cell group is deactivated, the terminal equipment performs beam failure detection of the primary secondary cell.

Abstract: An apparatus for configuring information, applicable to an IAB node, includes: a receiver configured to receive an RRC reconfiguration message, wherein the RRC reconfiguration message indicates information on a topology to which a default uplink BAP routing ID configured for the IAB node belongs.

Abstract: The present invention relates to tools and methods for the generation of antibodies which specifically bind chemokine receptors, such as CC or CXC chemokine receptors. Provided are isolated sulfated polypeptides and conjugates thereof, which can be used for example as antigens or for off target panning to facilitate the generation of anti-human, anti-cynomolgus, and/or anti-mouse chemokine receptor antibodies, e.g. for the generation of antibodies with fully human CDRs and/or other favorable properties for therapeutic use. The present invention furthermore relates to antibodies and conjugates thereof which can be obtained by applying the aforementioned tools and methods. Provided are antibodies specifically binding to human, cynomolgus and/or murine CCR8 with favorable properties for therapeutic use, such as cross-reactive antibodies, fully human antibodies, low internalizing (including non-internalizing) antibodies, and antibodies efficiently inducing ADCC and/or ADCP in Treg cells.

Abstract: A network integration apparatus for a node, configured in a first node, includes: a mobile termination module (MT) configured to control a forward module (Fwd) of the first node; and the Fwd configured to forward a signal between a network device and a terminal equipment; wherein the MT accesses to the network as a terminal equipment via an RRC (Radio Resource Control) connection management procedure, reports information indicating the type of the first node to the network device, and performs authorization with a core network via the network device, and the Fwd is started to serve user equipment(s).

Abstract: The present invention relates to tools and methods for the generation of antibodies which specifically bind chemokine receptors, such as CC or CXC chemokine receptors. Provided are isolated sulfated polypeptides and conjugates thereof, which can be used for example as antigens or for off target panning to facilitate the generation of anti-human, anti-cynomolgus, and/or anti-mouse chemokine receptor antibodies, e.g. for the generation of antibodies with fully human CDRs and/or other favorable properties for therapeutic use. The present invention furthermore relates to antibodies and conjugates thereof which can be obtained by applying the aforementioned tools and methods. Provided are antibodies specifically binding to human, cynomolgus and/or murine CCR8 with favorable properties for therapeutic use, such as cross-reactive antibodies, fully human antibodies, low internalizing (including non-internalizing) antibodies, and antibodies efficiently inducing ADCC and/or ADCP in Treg cells.

Abstract: A device identification apparatus, applicable to a first network device, the device identification apparatus includes: a receiver configured to receive first information transmitted by a first device, wherein, the first information is used to indicate that the first device is a Network-Controlled repeater or is used to determine that the first device connects to a network as a Network-Controlled repeater, or, the first information is repeater-specific first information.

Abstract: An access control apparatus, applicable to a repeater, includes: a receiver configured to receive SIB1 transmitted by a network device, the SIB1 including an access control parameter, and processor circuitry configured to control to not apply to a unified access control procedure which is performed by using the access control parameter.